Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Cancer Hospital of Chinese Academy of Medical Sciences · Beijing

Dr. Wang Hongyu王宏羽

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Wang Hongyu

Professional overview

Wang Hongyu is a Chief Physician in the Department of Medical Oncology at Cancer Hospital of Chinese Academy of Medical Sciences, specializing in medical treatment of lung cancer.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic roles—
DepartmentDepartment of Medical Oncology
HospitalCancer Hospital of Chinese Academy of Medical Sciences
CityBeijing

Areas of focus

Lung cancerMedical treatment of lung cancer, adjuvant chemotherapy after lung cancer surgery, targeted therapy after surgery for stage IIIA, N2-positive non-squamous NSCLC, comprehensive treatment of small cell lung cancer, targeted therapy for advanced driver gene-positive non-squamous NSCLC, chemotherapy for advanced driver gene-negative non-squamous NSCLC, and immunotherapy for advanced lung cancer (including squamous carcinoma and driver gene-negative non-squamous NSCLC)

Background

  • 1987Joined the tumor hospital after graduation in July

Experience & recognition

  • Over 30 years of clinical experience in medical oncology
  • Principal investigator for multiple new drug clinical trials at the GCP Center
  • Author of the monograph 'Relief of Cancer Pain and Palliative Treatment'
  • Contributor to 'Practical Medical Oncology', 'Diagnosis and Treatment of Lung Cancer', and 'Clinical Handbook of Medical Oncology'
  • Published more than 30 papers

Frequently asked questions

What does Dr. Wang Hongyu specialize in?

Medical treatment of lung cancer, including adjuvant chemotherapy after surgery, postoperative targeted therapy for stage IIIA N2-positive non-squamous NSCLC, comprehensive treatment of small cell lung cancer, targeted therapy for advanced driver gene-positive non-squamous NSCLC, chemotherapy for advanced driver gene-negative non-squamous NSCLC, and immunotherapy for advanced lung cancer (squamous and driver gene-negative non-squamous NSCLC)

Which hospital and department is Dr. Wang Hongyu in?

Department of Medical Oncology at Cancer Hospital of Chinese Academy of Medical Sciences

Sources

Dr. Wang Hongyu has not reviewed this page.